Telix Pharmaceuticals Limited Share Price
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.09 AUD | -1.55% |
|
+0.58% | -2.11% |
| Capitalization | 8.28B 5.43B 4.65B 4.33B 4.01B 7.44B 466B 51.81B 19.79B 218B 20.38B 19.96B 796B | P/E ratio 2025 * |
44.8x | P/E ratio 2026 * | 29.2x |
|---|---|---|---|---|---|
| Enterprise value | 8.42B 5.53B 4.73B 4.41B 4.08B 7.57B 474B 52.71B 20.13B 222B 20.74B 20.31B 810B | EV / Sales 2025 * |
6.61x | EV / Sales 2026 * | 5.11x |
| Free-Float |
58.65% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Telix Pharmaceuticals Limited
More recommendations
More press releases
More news
| 1 day | -1.55% | ||
| 1 week | +0.58% | ||
| Current month | -1.35% | ||
| 1 month | -7.27% | ||
| 3 months | -9.37% | ||
| 6 months | +0.42% | ||
| Current year | -2.11% |
| 1 week | 23.57 |  | 25.87 |
| 1 month | 22.76 | | 26.25 |
| Current year | 21.4 | | 31.97 |
| 1 year | 17.03 | | 31.97 |
| 3 years | 4.37 | | 31.97 |
| 5 years | 1.24 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 02/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 59 | 30/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 02/01/2017 | |
Mark Nelson
BRD | Director/Board Member | 65 | 16/09/2017 |
Jann Skinner
BRD | Director/Board Member | 67 | 18/06/2018 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 9 M€ | +15.58% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.55% | +0.58% | +37.26% | +342.02% | 5.43B | ||
| -0.98% | +1.22% | +10.51% | -0.95% | 50.45B | ||
| -0.93% | +4.53% | +67.38% | +42.31% | 30.01B | ||
| +1.42% | +5.74% | +4.18% | +11.14% | 28.73B | ||
| -1.81% | -0.62% | -23.00% | -24.92% | 28.64B | ||
| -0.20% | -0.85% | +26.70% | -22.30% | 12.7B | ||
| -1.54% | +1.58% | -55.14% | -30.13% | 12.08B | ||
| -0.08% | +0.43% | +30.23% | +94.71% | 10.69B | ||
| -1.07% | -0.60% | +13.86% | -5.46% | 10.51B | ||
| +0.77% | +1.40% | +56.85% | - | 10.32B | ||
| Average | -0.60% | -0.65% | +16.88% | +45.16% | 19.96B | |
| Weighted average by Cap. | -0.61% | -0.57% | +14.76% | +15.82% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.27B 836M 715M 667M 616M 1.14B 71.7B 7.97B 3.04B 33.5B 3.14B 3.07B 122B | 1.62B 1.06B 908M 846M 782M 1.45B 90.99B 10.12B 3.86B 42.51B 3.98B 3.9B 155B |
| Net income | 215M 141M 121M 112M 104M 193M 12.08B 1.34B 513M 5.64B 528M 517M 20.63B | 333M 219M 187M 174M 161M 299M 18.75B 2.08B 796M 8.76B 820M 803M 32.01B |
| Net Debt | 144M 94.62M 80.96M 75.44M 69.76M 129M 8.11B 902M 344M 3.79B 355M 348M 13.86B | -24.92M -16.35M -13.99M -13.04M -12.06M -22.38M -1.4B -156M -59.53M -655M -61.32M -60.07M -2.39B |
More financial data
* Estimated data
Employees
423
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/07/25 | 24.09 $ | -1.55% | 1,140,941 |
| 10/07/25 | 24.47 $ | -3.62% | 1,234,472 |
| 09/07/25 | 25.39 $ | +5.62% | 1,888,127 |
| 08/07/25 | 24.04 $ | -0.04% | 770,153 |
| 07/07/25 | 24.05 $ | -0.58% | 441,596 |
Delayed Quote Australian S.E., July 11, 2025 at 07:10 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
24.47AUD
Average target price
32.05AUD
Spread / Average Target
+30.97%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition